Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: An electrophysiological and c-Fos study

Neuroscience

Volumn 92, Issue 2, 1999, Pages 533-543

  Hassani, O K ^a   Feger J ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Dopamine; Early genes; Electrophysiology; Microinjection; Rat; Subthalamic nucleus

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; OXIDOPAMINE; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ELECTROPHYSIOLOGY; GENE EXPRESSION; IMMUNOREACTIVITY; MALE; MICROINJECTION; NONHUMAN; ONCOGENE C FOS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS;

EID: 0345188621     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00765-9     Document Type: Article

References (90)

1. Aghajanian G.K., Bunney B.S. Dopamine "autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies. Naunyn-Schmiedeberg's Arch. Pharmac. 297:1977;1-7.
2. Akaoka H., Charléty P., Saunier C.F., Buda M., Chouvet G. Inhibition of nigral dopamine neurons by systemic and local apomorphine: possible contribution of dendritic autoreceptors. Neuroscience. 49:1992;879-891.
3. Albin R.L., Youg A.B., Penney J.B. The functionnal anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
4. Albin R.L., Youg A.B., Penney J.B. The functional anatomy of disorders of the basal ganglia. Trends Neurosci. 18:1995;63-64.
5. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
6. Bell K., Churchill L., Kalivas P.W. GABAergic projection from the ventral pallidum and globus pallidus to the subthalamic nucleus. Synapse. 20:1995;10-18.
7. Bergman H., Wichman T., DeLong M.R. Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus. Science. 249:1990;1436-1438.
8. Bergman H., Wichmann T., Karmon B., Delong M.R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism. J. Neurophysiol. 72:1994;507-520.
9. Bevan M.D., Francis C.M., Bolam J.P. The glutamate-enriched cortical and thalamic input to neurones in the subthalamic nucleus of the rat: convergence with GABA-positive terminals. J. comp. Neurol. 361:1995;491-511.
10. 125I]iodosulpride. Neuroscience. 20:1987;117-155.
11. Bouthenet M.-L., Souil E., Martres P., Sokoloff P., Giros B., Schwartz J.-C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with D2 receptor mRNA. Brain Res. 564:1991;203-219.
12. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6:1986;3177-3188.
13. Bull D.R., Bakhtiar R., Sheehan M.J. Characterization of dopamine autoreceptors in the amygdala: a fast cyclic voltammetric study in vitro. Neurosci. Lett. 134:1991;41-44.
14. Calabresi P., De Murtas M., Mercuri N.B., Bernardi G. Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. Ann. Neurol. 31:1992;366-373.
15. Campbell G.A., Eckardt M.J., Weight F.F. Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res. 333:1985;261-270.
16. Canteras N.S., Shammah-Lagnado S.J., Silva B.A., Ricardo J.A. Somatosensory inputs to the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 458:1988;53-64.
17. Canteras N.S., Shammah-Lagnado S.J., Silva B.A., Ricardo J.A. Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513:1990;43-59.
18. Carlson J.H., Bergstrom D.A., Demo S.D., Walters J.R. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus. Synapse. 5:1990;83-93.
19. Chergui K., Nomikos G.G., Mathé J.M., Gonon F., Svensson T.H. Burst stimulation of the medial forebrain bundle selectively increases Fos-like immunoreactivity in the limbic forebrain of the rat. Neuroscience. 72:1996;141-156.
20. Chesselet M.F., Delfs J.M. Basal ganglia and movement disorders: an update. Trends Neurosci. 19:1996;417-422.
21. Cooper A.J., Mitchell I.J. Fos immune-positive neurons in the subthalamic nucleus following reversal of parkinsonian symptoms by antagonism of excitatory amino acid transmission in the entopeduncular nucleus of the monoamine depleted rat. Neurosci. Lett. 201:1995;251-254.
22. Curran E.J., Watson S.J. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. comp. Neurol. 361:1995;57-76.
23. Dal Toso R., Sommer B., Ewert M. The dopamine D2 receptor: two molecular forms generated by alternative splicing. Eur. molec. Biol. Org. J. 58:1989;4025-4034.
24. 1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand. Neuroscience. 26:1988;83-100.
25. DeLong M. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
26. Ehringer H., Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-hydroxy-tyramin) im Gehirn des menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen System. Wien Klin. Wschr. 72:1960;1236-1239.
27. Fonnum F., Gottesfeld Z., Grofova I. Distribution of glutamate decarboxylase, choline acetyltransferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres. Brain Res. 143:1978;125-138.
28. Garcia-Munoz M., Young S.J., Groves P.M. Presynaptic long-term changes in excitability of the corticostriatal pathway. NeuroReport. 3:1992;357-360.
29. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley R.S. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
30. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
31. Gonon F. Non-linear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 24:1988;19-28.
32. Hassani O.-K., Mouroux M., Féger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience. 72:1996;105-115.
33. Hassani O.K., Francois C., Yelnik J., Feger J. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res. 749:1997;88-94.
34. Hornykiewicz O. (1986) A quarter century of brain dopamine research. In Dopaminergic Systems and their Regulations (eds Woodruff G. N., Poat J. A. and Roberts P. J.), pp. 3-18. MacMillan, London.
35. Hsu K.S., Huang C.C., Yang C.H., Gean P.W. Presynaptic D-2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum. Brain Res. 690:1995;264-268.
36. Hsu S., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
37. Huang K.X., Walters J.R. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. J. Pharmac. exp. Ther. 271:1994;1434-1443.
38. Hudson J.L., Vanhorne C.G., Stromberg I., Brock S., Clayton J., Masserano J., Hoffer B.J., Gerhardt G.A. Correlation of apomorphine-induced and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 626:1993;167-174.
39. Johnson A.E., Coirini H., Kallstrom L., Wiesel F.A. Characterization of dopamine receptor binding sites in the subthalamic nucleus. NeuroReport. 5:1994;1836-1838.
40. Joyce E.M., Iversen S.D. Dissociable effects of 6-OHDA-induced lesions of neostriatum on anorexia, locomotor activity and stereotypy: the role of behavioural competition. Psychopharmacology. 83:1984;363-366.
41. Keefe K.A., Gerfen C.R. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience. 66:1995;903-913.
42. Kelland M.D., Soltis R.P., Anderson L.A., Bergstrom D.A., Walters J.R. In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizocilpine, and ketamine anesthesia. Synapse. 20:1995;338-350.
43. Kitai S.T., Deniau J.M. Cortical inputs to the subthalamic nucleus: intracellular analysis. Brain Res. 214:1981;481-492.
44. Kreiss D.S., Anderson L.A., Walters J.R. Apomorphine and dopamine D1 receptor agonists increase the firing rates of subthalamic neurons. Neuroscience. 72:1996;863-876.
45. Künzle H. Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca fascicularis. Brain Res. 88:1975;195-209.
46. Künzle H. Projections from the primary somatosensory cortex to basal ganglia and thalamus in the monkey. Expl Brain Res. 30:1977;481-492.
47. Lannes B. and Micheletti G. (1994) Glutamate-dopamine balance in the striatum: pre- and post-synaptic interactions. In The Basal Ganglia IV - New Ideas and Data on Structure and Functions (eds Percheron G., MacKenzie J. S. and Féger J.), pp. 475-789. Plenum, New York.
48. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. comp. Neurol. 355:1995;418-426.
49. Levy A.I., Hersch S.M., Rye D.B., Sunahara R.K., Niznik H.B., Kitt C.A., Price D.L., Maggio R., Brann M.R. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc. natn. Acad. Sci. U.S.A. 90:1993;8861-8865.
50. Levy R., Hazrati L.N., Herrero M.T., Vila M., Hassani O.K., Mouroux M., Ruberg M., Asensi H., Agid Y., Feger J., Obeso J.A., Parent A., Hirsch E.C. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience. 76:1997;335-343.
51. 2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 10:1990;2587-2600.
52. 1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience. 46:1992;959-971.
53. Mansour A. and Watson S. J. Jr (1995) Dopamine receptor expression in the central nervous system. In Psychopharmacology: The Fourth Generation of Progress (eds Bloom F. E. and Kupfer D. J.), pp. 207-219. Raven, New York.
54. Martin L.P., Waszczak B.L. Dopamine d-2 receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons. Brain Res. 729:1996;156-169.
55. 125I-iodosulpiride, a highly selective ligand. Science. 228:1985;752-755.
56. Meador-Woodruff J.H., Mansour A., Bunzow J.R., Van Tol H.H.M., Watson S.J., Civelli O. Distribution of D2 dopamine receptor mRNA in rat brain. Proc. natn. Acad. Sci. U.S.A. 86:1989;7625-7628.
57. Meibach M.R.C., Katzman R. Catecholaminergic innervation of the subthalamic nucleus: evidence for a rostral continuation of A9 (substantia nigra) dopaminergic group. Brain Res. 173:1979;364-368.
58. Menétrey D., De Pommery J., Baimbridge K.G., Thomasset M. Calbindin-D28K (Ca BP28K)-like immunoreactivity in ascending projections. I. Trigeminal nucleus caudalis and dorsal vagal complex projections. Eur. J. Neurosci. 4:1992;61-69.
59. Miller W. C. and DeLong M. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of Parkinsonism. In The Basal Ganglia II: Structure and Function - Current Concepts (eds Carpenter M. B. and Jayarman A.), pp. 415-427. Plenum, New York.
60. Mintz I., Hammond C., Féger J. Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus. Brain Res. 375:1986;172-175.
61. Mitchell I.J., Clarke C.E., Boyce S., Robertson R.G., Peggs D., Sambrook M.A., Crossman A.R. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroscience. 32:1989;213-226.
62. Mitchell I. J., Cross A. J., Sambrook M. A. and Crossman A. R. (1986) N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in the monkey: neurochemical pathology and regional brain metabolism. J. neural Transm. Suppl. XX 41-46.
63. Monsma J.F., Mahan L.C., McVittie L.D., Gerfen C.R., Sibley D.R. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc. natn. Acad. Sci. U.S.A. 87:1990;6723-6727.
64. Mouroux M., Féger J. Evidence that the parafascicular projection to the subthalamic nucleus is glutamatergic. NeuroReport. 4:1993;613-615.
65. Nicol B., Rowbotham D.J., Lambert D.G. Glutamate uptake is not a major target site for anaesthesic agents. Br. J. Anaesth. 75:1995;61-65.
66. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. 2. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20:1995;128-154.
67. Parry T.J., Eberle-Wang K., Lucki I., Chesselet M.-F. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Expl Neurol. 128:1994;181-190.
68. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.
69. Pennartz C.M.A., Dolleman-Van der Well M.J., Kitai S.T., Lopes da Silva F.H. Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the nucleus accumbens studies in vitro. J. Neurophysiol. 67:1992;1325-1334.
70. Pralong E., Jones R.S.G. Interactions of dopamine with glutamate-mediated and GABA-mediated synaptic transmission in the rat entorhinal cortex in vitro. Eur. J. Neurosci. 5:1993;760-767.
71. Robertson H.A., Paul M.L., Moratella R., Graybiel A.M. Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Can. J. neurol. Sci. 18:1991;380-383.
72. Robertson H.A., Peterson M.R., Murphy K., Robertson G.S. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res. 503:1989;346-349.
73. Robledo P., Féger J. Acute monoaminergic depletion in the rat potentiates the excitatory effect of the subthalamic nucleus in the substantia nigra par reticulata but not in the pallidal complex. J. neural Transm. (Gen. Sect.). 86:1991;115-126.
74. Rouzaire-Dubois B., Hammond C., Hamon B., Féger J. Pharmacological blockade of the globus pallidus-induced inhibitory responses of the subthalamic cells in the rat. Brain Res. 200:1980;321-329.
75. Rouzaire-Dubois B., Scarnati E. Increase in glutamate sensitivity of subthalamic neurons following bilateral decortication: a microiontophoretic study in the rat. Brain Res. 403:1987;366-370.
76. Rouzaire-Dubois B., Scarnati E. Pharmacological study of the cortical-induced excitation of subthalamic nucleus neurones in the rat: evidence for amino acids as putative neurotransmitters. Neuroscience. 21:1987;429-440.
77. 3H]SCH 23390. Brain Res. 375:1986;291-301.
78. Sgambato V., Abo V., Rogard M., Besson M.J., Deniau J.M. Effect of electrical stimulation of the cerebral cortex on the expression of the Fos protein in the basal ganglia. Neuroscience. 81:1997;93-112.
79. Smith Y., Bolam J.P., Von Krosigk M. Topographical and synaptic organization of the GABA-containing pallido-subthalamic projection in the rat. Eur. J. Neurosci. 2:1990;500-511.
80. Stoof J.C., Kebabian J.W. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 35:1984;2281-2296.
81. Thomson A.M., West D.C., Lodge D. An NMDA receptor mediated synapse in rat cerebral cortex: a site of action for ketamine. Nature. 313:1985;479-481.
82. 1A receptor. Proc. natn. Acad. Sci. U.S.A. 88:1991;7491-7495.
83. Trugman J.M. D1/D2 actions of dopaminergic drugs studied with [C-14]-2-deoxyglucose autoradiography. Prog. Neuro-Psychiat. Biol. Psychiat. 19:1995;795-810.
84. Wang J.Q. Regulation of immediate early gene c-fos and zif/268 mRNA expression in rat striatum by metabotropic glutamate receptor. Molec. Brain Res. 57:1998;46-53.
85. Wang J.Q., McGinty J.F. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum. Molec. Brain Res. 54:1998;262-269.
86. Weiner D.M., Levey A.I., Sunahama R.K., Niznik H.B., O'Dowd B.F., Seeman P., Brann M.R. D1 and D2 dopamine receptor mRNA in rat brain. Proc. natn. Acad. Sci. U.S.A. 88:1991;1859-1863.
87. Wichmann T., Bergman H., Delong M.R. The primate subthalamic nucleus. 3. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of Parkinsonism. J. Neurophysiol. 72:1994;521-530.
88. Wolfson L., Brown L. L., Makman M., Warner C., Dvorkin B. and Katzman R. (1982) Dopamine mechanisms in the subthalamic nucleus and possible relationship to hemiballismus and other movement disorders. In Gilles de la Tourette Syndrome (eds Friedhoff A. J. and Chase T. N.), pp. 203-211. Raven, New York.
89. Yamamura T., Harada K., Okamura A. Is the site of action of ketamine anaesthesia the N-methyl-D-aspartate receptor? Anesthesiology. 72:1990;704-710.
90. Zoltay G., Cooper J.R. Presynaptic modulation by dopamine and GABA opens a potassium channel in rat cortical, striatal and hippocampal synaptosomes via eicosanoids. Neurochem. Int. 25:1994;345-348.